Cognitive Dysfunction

34 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Cognition Disorders, Mental Disorders

Treatments and conditions

Cognitive Dysfunction
Treatment and conditionWhere it standsTrials
Active tDCS with Sternberg task for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Aducanumab for cognitive dysfunctionTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
ATTN201 Focused Ultrasound to the CMN for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Audiovisual stimulation VR system for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Buntanetap tartrate for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth) for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical Lymphovenous Anastomosis + Routine Treatment for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Device-only fitting for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Exablate Model 4000 Type 2 + ADUCANUMAB + LECANEMAB for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Facilitate tDCS + CR for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fasudil for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Focused Transcranial Ultrasound for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
GENUS device (Active Settings) for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ginkgo for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
human Mesenchymal Stem Cells for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lecanemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
LY-2599666 for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mad for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Metformin hydrochloride for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nicotinamide Riboside (NR) for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + ADUCANUMAB for cognitive dysfunctionTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Receive tDCS+CR for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
RP902 for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sense4Safety for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Service-only Fitting for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium oligo-mannurarate 600mg for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium oligo-mannurarate 900mg for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Solanezumab for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Task-oriented resistance exercise for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
tributyrin for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Trontinemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Valacyclovir for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vericiguat for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.